Abstract:The study provides quantitative data of immune‐associated proteins such as major histocompatibility complex (MHC)‐1, (MHC)‐2 and intercellular adhesion molecule (ICAM)‐1 at protein and gene levels. The findings can be integrated into our pathophysiological understanding of IIM. There is evidence that vascular pathology, seen in ASyS, DM and COVID19, may be associated with an ICAM‐1‐mediated endothelial activation. Furthermore, our data introduce ICAM‐1 as a new specific diagnostic marker for morphological classification of myositis. Aims Diagnosis of idiopathic inflammatory myopathies (IIM) is based on morphological characteristics and the evaluation of disease‐related proteins. However, although broadly applied, substantial bias is imposed by the respective methods, observers and individual staining approaches. We aimed to quantify the protein levels of major histocompatibility complex (MHC)‐1, (MHC)‐2 and intercellular adhesion molecule (ICAM)‐1 using an automated morphometric method to mitigate bias. Methods Double immunofluorescence staining was performed on whole muscle sections to study differences in protein expression in myofibre and endomysial vessels. We analysed all IIM subtypes including dermatomyositis (DM), anti‐synthetase syndrome (ASyS), inclusion body myositis (IBM), immune‐mediated‐necrotising myopathy (IMNM), dysferlinopathy (DYSF), SARS‐CoV‐2 infection and vaccination‐associated myopathy. Biopsies with neurogenic atrophy (NA) and normal morphology served as controls. Bulk RNA‐Sequencing (RNA‐Seq) was performed on a subset of samples. Results Our study highlights the significance of MHC‐1, MHC‐2 and ICAM‐1 in diagnosing IIM subtypes and reveals distinct immunological profiles. RNASeq confirmed the precision of our method and identified specific gene pathways in the disease subtypes. Notably, ASyS, DM and SARS‐CoV‐2‐associated myopathy showed increased ICAM‐1 expression in the endomysial capillaries, indicating ICAM‐1‐associated vascular activation in these conditions. In addition, ICAM‐1 showed high discrimination between different subgroups with high sensitivity and specificity. Conclusions Automated morphometric analysis provides precise quantitative data on immune‐associated proteins that can be integrated into our pathophysiological understanding of IIM. Further, ICAM‐1 holds diagnostic value for the detection of IIM pathology.

CD44 is associated with muscle inflammation in polymyositis and skin damage in idiopathic inflammatory myopathy

Polymyositis and Dermatomyositis Biomarkers

Expression of the CD85j (leukocyte Ig-like receptor 1, Ig-like transcript 2) receptor for class I major histocompatibility complex molecules in idiopathic inflammatory myopathies

The muscle tissue transcriptome of idiopathic inflammatory myopathy reflects the muscle damage process by monocytes and presence of skin lesions

Expression of CD163 and major histocompatibility complex class I as diagnostic markers for idiopathic inflammatory myopathies

Expression of membrane attack complex in common idiopathic inflammatory myopathy

Coexpression Network Analysis Coupled with Connectivity Map Database Mining Reveals Novel Genetic Biomarkers and Potential Therapeutic Drugs for Polymyositis

MicroRNA and mRNA profiling in the idiopathic inflammatory myopathies

Differentiating idiopathic inflammatory myopathies by automated morphometric analysis of MHC‐1, MHC‐2 and ICAM‐1 in muscle tissue

Type 1 interferon signature in peripheral blood mononuclear cells and monocytes of idiopathic inflammatory myopathy patients with different myositis-specific autoantibodies

Serum metabolomic analysis reveals disorder of steroid hormone biosynthesis in patients with idiopathic inflammatory myopathy

A retrospective study for clinical characteristics of 293 patients with dermatomyositis

Phenotyping of myocardial involvement by cardiac magnetic resonance in idiopathic inflammatory myopathies

Serum cytokine profiles of adults with idiopathic inflammatory myopathies

Identification of Feature Genes and Key Biological Pathways in Immune-Mediated Necrotizing Myopathy: High-Throughput Sequencing and Bioinformatics Analysis

Pathogenic mechanisms of disease in idiopathic inflammatory myopathies: autoantibodies as clues

Op-brhe180346 511..521

CD163+ macrophage density in perimysial connective tissue associated with prognosis in IMNM

Peripheral Blood Lymphocyte Subsets and Heterogeneity of B Cell Subsets in Patients of Idiopathic Inflammatory Myositis with Different Myositis-specific Autoantibodies

Clinical characteristics of idiopathic inflammatory myopathies patients with anti-PM/Scl antibodies

Immunogenetic risk and protective factors for the idiopathic inflammatory myopathies: distinct HLA-A, -B, -Cw, -DRB1 and -DQA1 allelic profiles and motifs define clinicopathologic groups in caucasians.